MétaCan
Menu
Back to cohort

A secondary analysis of depression outcomes from a randomized controlled trial of adjunctive sertraline for HIV-associated cryptococcal meningitis

2022· preprint· en· W4309835412 on OpenAlexfundno aff
Sarah M Lofgren, SRUTI S VELAMAKANNI, Kathy Huppler Hullsiek, Ananta Bangdiwala, Alice Namudde, Abdu K Musubire, Edward Mpoza, Mahsa Abassi, Katelyn A Pastick, Edwin Nuwagira, Emily E Evans, Radha Rajsasingham, Darlisha A Williams, Conrad Muzoora, Fiona V. Creswell, Joshua Rhein, David J. Bond, Noeline Nakasujja, David B. Meya, David R. Boulware

Bibliographic record

VenueWellcome Open Research · 2022
Typepreprint
Languageen
FieldMedicine
TopicHIV/AIDS Research and Interventions
Canadian institutionsnot available
FundersNational Institute of Allergy and Infectious DiseasesGrand Challenges CanadaWellcome TrustNational Institute of Neurological Disorders and StrokeNational Institute of Mental HealthMedical Research CouncilDepartment for International DevelopmentFogarty International CenterGilead Sciences
KeywordsSertralineDepression (economics)PlaceboMedicinePopulationRandomized controlled trialInternal medicinePsychiatryAntidepressantPathology

Abstract

fetched live from OpenAlex

<ns4:p> <ns4:bold>Background</ns4:bold> : Depression is a risk factor for worse HIV outcomes in persons living with HIV/AIDS, including engagement-in-care, HIV medication adherence, and retention-in-care. Depression has a prevalence of more than three times as high as in the general population. Despite this, there are few randomized studies of antidepressants in HIV-infected Africans, including those with opportunistic infections. </ns4:p> <ns4:p> <ns4:bold>Methods:</ns4:bold> We enrolled 460 HIV-infected Ugandans with cryptococcal meningitis into a randomized clinical trial of adjunctive sertraline vs placebo (2015-2017). We defined depression using the Center for Epidemiologic Studies Depression Scale (CES-D) score of &gt;15, and severe depression as &gt;26 at one and three months after meningitis diagnosis and initiation of treatment. We evaluated the relationship between sertraline and depression, as well as associations with persistent depression, at three months. </ns4:p> <ns4:p> <ns4:bold>Results:</ns4:bold> At one- and three-months post meningitis diagnosis, 62% (108/174) and 44% (74/169) of all subjects had depression (CES&gt;15), respectively. At three months, sertraline-treated subjects had consistent risk for depression as placebo-treated subjects but were significantly less likely to have severe depression (CES&gt;26) (OR 0.335; 95%CI, 0.130-0.865). Of those with depression at one month, sertraline-treated subjects were less likely than placebo-treated subjects to be depressed at three months (p=0.05). Sertraline was the only factor we found significant in predicting persistent depression at three months among those with depression at one month. </ns4:p> <ns4:p> <ns4:bold>Conclusions:</ns4:bold> Depression is highly prevalent in HIV-infected persons who have survived cryptococcal meningitis. We found that sertraline is associated with a modest reduction in depression in those with depression at baseline and a significant decrease in severe depression. </ns4:p>

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame distilled prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. Learned from the 10,348 direct Codex labels and 10,348 direct Gemma labels. Candidate is the union of thresholded teacher heads; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels or direct frontier model labels.

metaresearch head score (Codex)0.018
metaresearch head score (Gemma)0.018
Version: codex-gemma-dda1882f352aValidation status: machine_predicted_unvalidated
Candidate categoriesMetaresearch, Meta-epidemiology (narrow), Insufficient payload (model declined to judge)
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Randomized trial · Consensus signal: Randomized trial
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.055
Threshold uncertainty score1.000

Codex and Gemma teacher scores by category

CategoryCodexGemma
Metaresearch0.0180.018
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0090.005
Bibliometrics0.0030.002
Science and technology studies0.0000.001
Scholarly communication0.0000.000
Open science0.0020.004
Research integrity0.0000.002
Insufficient payload (model declined to judge)0.0280.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.104
GPT teacher head0.450
Teacher spread0.346 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one teacher head, not a consensus.

Study designRandomized trial
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations0
Published2022
Admission routes1
Has abstractyes

Explore more

Same venueWellcome Open ResearchSame topicHIV/AIDS Research and InterventionsFrench-language works237,207